Subclinical Pre-Treatment Sensory Deficits Appear to Predict the Development of Pain and Numbnessin Patients with Multiple Myeloma Undergoing Chemotherapy

PURPOSE: Chemotherapy-induced peripheral neuropathy is a major complication in the treatment of cancer, including multiple myeloma (MM). Patients may develop painful and nonpainful (e.g., numbness) neuropathy symptoms that impair function and often persist after therapy is terminated. This study tes...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Vichaya, Elisabeth G., Wang, Xin Shelley, Boyette-Davis, Jessica A., Mendoza, Tito R., He, Zijing, Thomas, Sheeba K., Shah, Nina, Williams, Loretta A., Cleeland, Charles S., Dougherty, Patrick M.
Format: Artigo
Jezik:Inglês
Izdano: 2013
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3669643/
https://ncbi.nlm.nih.gov/pubmed/23543296
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-013-2152-7
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki